Jun 23 |
Lilly, Novo Nordisk to dominate weight loss therapy market: SA Investing Summit
|
Jun 21 |
The 30-stock secret: ‘Don’t fight Papa Dow’
|
Jun 21 |
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
|
Jun 20 |
Amgen (AMGN) Gains As Market Dips: What You Should Know
|
Jun 20 |
Where Will Amgen Be in 5 Years?
|
Jun 17 |
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
|
Jun 17 |
Amgen: You Haven't Seen Anything Yet
|
Jun 17 |
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
|
Jun 17 |
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
|
Jun 14 |
FDA grants expanded approval for Amgen's Blincyto in ALL
|